Tiidal Gaming Group Corp (CSE:TIDL), an esports and gaming platform company, said it will host an investor webinar on Wednesday, January 5, 2022 at 1pm EST to discuss the company's overall growth strategy in accordance with the recent appointment of Tom Hearne as its CEO. Hearne will present during the webinar and share his vision for the firm. The presentation will be followed by a Q&A session during which he will address investor questions. To register, click here. People are asked to submit any questions to ir@tiidal.gg before or during the event.
Fortitude Gold (OTCQB:FTCO) (Fortitude Gold (OTCQB:FTCO)) Corp announced that it has filed a plan of operation with the Bureau of Land Management (BLM) for the Golden Mile project located in Mineral County, Nevada. The Colorado Springs, Colorado-based company said that the proposed operations at Golden Mile include an open-pit mine and heap leach process taking gold to the carbon phase, after which processing the loaded carbon into gold doré utilizing the nearby Isabella Pearl ADR plant. Fortitude Gold (Fortitude Gold (OTCQB:FTCO)) released an initial resource for its Golden Mile property in November 2021, which included a mineral resource of 78,500 gold ounces at a grade of 1.13 grams per tonne (g/t) in the indicated category, and 84,500 gold ounces at 1.10 g/t in the inferred category.
Vicinity Motor Corp said that it has received a significant order from Olathe Fleet Solutions — a commercial truck dealership and fleet management in Kansas — for over 150 VMC Optimal E1 electric chassis valued in excess of US$19 million. The company said that the VMC Optimal E1 orders are scheduled for delivery throughout 2022 for operation in school, commercial, shuttle, ambulance, last-mile and other key market segments. "Olathe is well respected and highly rated in the commercial fleet market. This order is the culmination of effort and development which began many months ago with the Olathe team and key end-user involvement," said William Trainer, CEO of Vicinity in a statement. "As an authorized Ford ship-through upfitter, Olathe will be able to offer best-in-class EV solutions for customers across the Class 4 commercial vehicle spectrum.”
Zynerba Pharmaceuticals (NASDAQ:ZYNE) Inc has provided program updates for Fragile X syndrome (FXS), autism spectrum disorder (ASD), 22q11.2 deletion syndrome (22q), and developmental and epileptic encephalopathies (DEE). In addition to the continued clinical development of its Zygel CBD gel in FXS, the company said it plans to focus on the development of Zygel in ASD and 22q. However, the company added that based on its research and strategic prioritization, the decision has been made to not move forward in DEE at this time.
Vuzix Corporation (NASDAQ:VUZI) announced that it has introduced the Vuzix M400-C smart glasses, the latest edition to its M-Series smart glass family. The company told its investors that it has shipped its limited initial production units to a Windows computer manufacturer. The Rochester, New York-based company said that further shipments are expected to be made to select partners in the first quarter of 2022 with full production on general availability commencing in the second quarter of 2022. "The M400-C is an ideal solution for enterprise customers that are looking for either an addition to an existing smartphone or a Windows-based computer to run on. It targets similar general use cases as our M400, but just plugs into another device to serve as a very capable tethered USB-C peripheral," said Paul Travers, CEO of Vuzix in a statement.
One World Lithium Inc revealed drill hole sample results from a four-hole program on its Salar del Diablo lithium brine project in Mexico. Project operators Montgomery & Associates (M&A) were contracted to oversee drilling on the Salar, a 103,450-hectare property in the State of Baja California. The exploration company said that, based on the results of chemical analysis, the basin contains fresh water and less than 5 parts per million (ppm) lithium.
Avalon GloboCare Corp (NASDAQ:AVCO) told investors it is 'well positioned' to execute on its growth strategy this year as the company highlighted it had partnered with world-renowned research centers and universities. In a year-end update, the clinical-stage, cell therapy company noted its new collaboration with the University of Pittsburgh Medical Center (UPMC) to develop new cancer immunotherapy approaches and streamline manufacturing processes. Avalon’s lead candidate AVA-011, combines the firm's FLASH-CAR technology with an innovative messenger ribonucleic acid (mRNA) based technology platform, and is currently at an investigational new drug (IND)-enabling stage. Avalon is on track to initiate AVA-011 first-in-human clinical trial by mid-2022, the company noted. It also reported that it had decided not to move ahead with the SenlangBio acquisition.
FansUnite Entertainment Inc (CSE:FANS, OTCQX:FUNFF) said it has strengthened its senior leadership team by appointing Dennis Williams as its payments director, as the global sports and entertainment company eyes rapid expansion. Prior to joining FansUnite, Williams was a payments senior specialist at the British Columbia Lottery Corporation, the only licensed provider of casinos, lottery products, and online gambling in British Columbia. He was one of the architects of the corporation’s payments-related strategies and implemented solutions for processing millions of dollars annually. He has also been the director of payment processing at a top European online poker network. FansUnite said Williams will oversee its payment solutions and will be working closely with the casino, iGaming, esports and sports betting divisions to streamline its payments and deposit and withdrawal processes.
Mobilum Technologies Inc said that it has appointed Kasha Piquette and Robert Niziol, two senior leaders in the fin-tech space, to its board of directors. "I am very excited to have Kasha and Robert join the board. Their seasoned experience in crypto, blockchain, and the financial markets are a welcomed addition to the team, and I look forward to kicking off the new year by continuing the momentum which we built throughout 2021,” said Mobilum CEO Wojciech Kaszycki in a statement. The company noted that Piquette's international leadership experiences in banking, investment management, and capital markets with a special interest in ESG (Environment, Social and Governance) issues have fortified her ability to skillfully navigate complex financial matters in service of her teams and clients including the province of Alberta. The company noted that Niziol has over 25 years of experience in capital markets, venture capital, private equity, management, and business consulting. Since 2005, he has been a partner at Penton Partners, a private equity fund investing in lower middle-market private companies, in Poland.
Gevo Inc (NASDAQ:GEVO) has announced the hiring of David George as senior vice president of its Verity Tracking unit. Gevo said George brings over 20 years of experience in technical commercial and business development leadership with a particular emphasis on blockchain technology. Before joining Gevo, he served as the chief commercial officer at Xpansiv Inc, a leading enterprise ESG blockchain infrastructure company, where he was responsible for building the market and product strategy for the very first blockchain-enabled tokenized commodities platform. He also served as the chief commercial officer at Gem, Inc where he helped establish and launch some of the very first enterprise blockchains globally. “Dave is a seasoned executive who brings a deep technical, product, and market expertise to the table,” Gevo chief carbon officer and chief innovation officer Dr Paul Bloom said in a statement.
Vejii Holdings (CSE:VEJI) Ltd told investors it has completed the acquisition of VEDGEco USA Inc, a leading online business-to-business (B2B) wholesale platform for plant-based products. The total purchase price for the acquisition, which closed on December 31, 2021, was US$6.25 million, the Vancouver-based company added. "I would personally like to thank our advisors and team members on both sides who worked tirelessly over the holidays to ensure we close this transaction before year-end,” CEO Kory Zelickson said in a statement. “This allows our new combined teams to hit the ground running in 2022, and focus on growing our businesses and onboarding new customers and products to our platforms.”
Tiidal Gaming Group Corp (CSE:TIDL) told investors it has appointed tech veteran Tom Hearne as its CEO and member of its board of directors. The esports and gaming platform company said Hearne has extensive experience as a senior executive having scaled publicly traded technology companies, including in his roles as past chief financial officer of theScore, OpenText, and London Stock Exchange-listed Sportech. Tiidal noted that throughout his career, Hearne has on multiple occasions led companies through their rapid growth stage from startup revenues through $100 million run rates and has been an instrumental part in numerous financing efforts, raising over $500 million.
CULT Food Science Corp said its portfolio company CELL AG TECH has achieved meaningful scientific and product development milestones over the last year in its pursuit to develop premium, cell-based seafood products such as snapper, cod, and halibut. In collaboration with food scientists at the Guelph Food Innovation Centre, CULT noted that its portfolio company has developed its inaugural prototype of a premium cell-based seafood offering. CULT added that this is a critical step for CELL AG TECH as the cultured seafood industry is very much in its infancy and the establishment of a scalable prototype is crucial to better understand the commercial viability, scope, and product-market fit.
Looking Glass Labs Ltd announced that its subsidiary House of Kibaa has become a video game/integrated device manufacturer (IDM) company member of the Creative Technology Association of British Columbia (DigiBC) to further its non-fungible tokens (NFT) and metaverse opportunities. DigiBC is a non-profit industry group for the creative tech sector in British Columbia, where Looking Glass recently established its global corporate headquarters. Through DigiBC, Looking Glass intends to explore opportunities for NFTs, utility NFTs (uNFTs) and metaverse-related technologies to potentially be added to the scope of interactive digital media in the context of public policy relating to digital art creations. Further, Looking Glass said that it plans to participate in several of DigiBC’s member offerings such as academic research partnerships, B2B networking, and industry events.
PowerTap Hydrogen Capital Corp said its investee, FusionOne Energy Corp, has continued its efforts to commercialize its HydroPlas plastic to hydrogen reactor and is on track to have the first system operational in the first half of 2022. In April 2021, PowerTap announced its purchase of a 5% stake in FusionOne, a producer of technologies for the conversion of plastic waste to hydrogen and clean electricity. The privately-owned technology company specializes in renewable energy, hydrogen production and thermal processing technologies. “FusionOne has continued its efforts to commercialize its HydroPlas Reactor with plastic polymer feedstocks and a number of other carbon-based waste feedstocks and is on track to have the first system operational in the first half of 2022 as planned,” PowerTap said in a corporate update.
BlueRush Inc has announced that its revenue jumped by a third for the first quarter of fiscal 2022 as it achieved a number of significant milestones in terms of new and existing customers. The company reported revenue of $1,110,078 for the three months ended October 31, 2021, up 33% from $836,511 in 1Q 2021. Total gross profit increased by 69% to $795,711 from $470,053 in the prior comparable quarter, with the contribution from software as a service (SaaS) gross profit rising to 90%. "We are extremely pleased with the way the fiscal year has started for BlueRush as we continue to see acceleration in terms of new signed customers, expansion from our existing customers and contribution from our growing partner network,” CEO Steve Taylor said in a statement.
Empower Clinics Inc announced that its MediSure Canada subsidiary has received new Health Canada Medical Device Licences for two healthcare products. These include a Class 3 Medical Device Licence under the number 107186 for the commercialization of its next MediSure Empower Blood Glucose (BGM) Monitoring, and a Class 2 Medical Device Licence under the number 107206 for the commercialization of a Medisure Vitamin D Rapid Test. The company noted that MediSure Canada has over two decades of experience in the diabetic management healthcare industry and is expanding its product line to provide innovative solutions to Canadians living with diabetes. The latest BGM product augments its existing line by providing a system with state-of-the-art Bluetooth capabilities, allowing patients to instantly connect their health information to their phone through a lighter and more compact medical device.
Albert Labs Inc has said that the recent guidance provided by the UK’s Medicines and Healthcare product Regulatory Agency (MHRA) supports the company’s strategy to use the Real World Evidence approach for regulatory approval. On December 17, MHRA produced guidance acknowledging and setting out criteria for the use of Real World Data and Evidence in regulatory decision making. The guidance emphasizes that a study or studies considered under this guidance need to be of the same standard as would be expected from a traditional Randomized Control Trial (RCT). The guidance further states that well-designed and conducted prospective RCTs provide a high level of evidence irrespective of the categorization of the data source.
American Battery Technology Company (OTCQB:ABML) CEO Ryan Melsert has told shareholders that the company is “excited” to now be constructing its first pre-commercial integrated facility. In a letter to shareholders, Melsert said that over the past two years, ABTC has been able to complete the analytical modeling and empirical validations portion of the design cycle for its lithium-ion battery recycling technologies, and has progressed to the integrated demonstration and piloting stage. “We are excited to now be constructing our first pre-commercial integrated facility to be able to operate these systems in a continuous and economically competitive fashion. This facility is designed to produce nearly every component needed to manufacture a new lithium-ion battery cell, and to demonstrate the true closed loop environment enabled by the operations of this recycling facility,” Melsert said in the letter.
CO2 GRO Inc (TSX-V:GROW, OTCQB:BLONF) has announced that a commercial feasibility of a CO2 Delivery Solutions system will commence in the first quarter of 2022 at a California greenhouse. The owners, who wished to be unnamed for competitive reasons, are expanding their 1-hectare greenhouse facility by another 2 hectares during 2022, totalling 3 hectares of production area (over 300,000 square feet). CO2 GRO said the commercial feasibility will run for a minimum of six months from installation. The main benefits being evaluated include increased production, faster growth, CO2 consumption and Pathogen Perimeter Protection which suppresses the development of micro-pathogens contributing to improved yields.
Genprex Inc announced that it has expanded its oncology research and development pipeline to include small cell lung cancer (SCLC) as an additional disease indication for its lead drug candidate REQORSA Immunogene Therapy. SCLC represents around 10%-15% of the lung cancer market, while REQORSA’s initial target indication of non-small cell lung cancer (NSCLC) represents about 84% of the lung cancer market. “Data from human studies indicate that REQORSA could be beneficial in targeting small cell lung cancer,” said Dr Mark Berger, chief medical officer at Genprex, in a statement. “Like non-small cell lung cancer, small cell lung cancer consistently has low TUSC2 protein levels and is documented to often have deletion of one TUSC2 gene allele. Extensive stage small cell lung cancer has a very poor prognosis, with a median progression-free survival of 5.2 months. Expanding the therapeutic indications targeted by REQORSA to include small cell lung cancer may provide us with another important clinical opportunity to combine REQORSA with small cell lung cancer therapies, including checkpoint inhibitors," he added.
Wishpond Technologies Ltd told investors it has completed its previously announced acquisition of certain assets and specific liabilities of AtlasMind Inc’s Winback.chat product. The Vancouver, British Columbia-based digital solutions company said it paid a total consideration of US$700,000 for the acquisition, entirely from cash on hand. It noted that New York-based Winback provides it with user-friendly and automated SMS marketing solutions, including a cart abandonment tool that can also be sold to its existing e-commerce clients, thereby creating a stickier offering.
Mirasol Resources Ltd has announced the promotion of experienced finance executive and high performer Carmen Cazares to chief financial officer to boost the exploration company’s senior management team. Cazares joined Mirasol in 2019 and previously served as the Vancouver, British Columbia-based company’s corporate controller. She is a member of the Chartered Professional Accountants of British Columbia and has a broad operational and accounting background with over 30 years of experience. Prior to joining Mirasol, Cazares served as corporate controller at Coro Mining Corp in Vancouver and at Endeavour Silver Corp (TSX:EDR) in Mexico. She earned a Bachelor of Commerce degree from the University of Chihuahua, in Mexico.
Pure Gold Mining Inc has announced a series of management changes - as it continues to work to unlock the full potential of its flagship PureGold mine in Red Lake, Ontario - and has provided a production summary for the fourth quarter. Commercial production was declared at the new Canadian mine on August 1 this year and Maryse Bélanger was named mine general manager in November. In six years, the mine has been transformed from a pre-resource stage asset through construction toward a commercial operation. "It is an incredible achievement, especially during a pandemic," Bélanger told investors in a statement. "Today we have a fully built mine site with an 800 tpd mill currently achieving +95% recoveries which can operate at 125% of nameplate capacity. Despite that success, much work remains to unlock the mine’s full potential."
Bam Bam Resources (CSE:BBR) Corp told investors that Larry Segerstrom, an experienced geologist with "extensive experience in the discovery and advancement of porphyry copper-gold projects" has joined the board of directors. From 2015 to 2020, he worked for Azucar Minerals, exploring and developing the El Cobre project, in the state of Veracruz, Mexico, an 11,860-hectare property which contains copper-gold porphyry mineralization over four kilometers (km) of strike. Segerstrom has also been involved in several discoveries, including leading teams that developed new ore reserves totaling 3.4 billion pounds of copper and 3.6 million ounces of gold at Freeport's giant Grasberg copper-gold porphyry district in Germany.
Belmont Resources Inc (TSX-V:BEA) has said that further to its news release of November 4, 2021, regarding the Option Agreements on the Lone Star-Washington and Kibby Basin-Nevada properties with Marquee Resources Ltd (ASX:MQR), it wishes to clarify the Finder’s Fee agreement with an unrelated arm’s length third party. The company said it has agreed, subject to regulatory approval to issue a total of two times 250,000 common shares at a deemed price of $0.06 per share. The finder’s fee is related to the introduction of both the Lone Star project and the Kibby Basin projects to Marquee Resources by the same unrelated arm’s length third party.
Algernon Pharmaceuticals Inc said it has granted 96,000 stock options exercisable at $4.10 for five years from date of grant, for officers and directors, employees and a consultant and are subject to approval by regulatory authorities.
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) has announced that it will participate in the H.C. Wainwright BioConnect Conference to be hosted virtually on January 10-13, 2022. A corporate presentation from James Lanthier, CEO of Mindset, will be available on-demand starting Monday, January 10, 2022, at 7.00am ET. To view, investors can register here: https://journey.ct.events/view/08faf8db-961d-4f79-8101-43911062ade6. The company also announces that it has engaged Emerging Markets Consulting, LLC to provide investor/public relations services. Based in Orlando, Florida, with affiliates around the world, EMC is an international investor relations firm that brings decades of combined experience in the investor relations industry. Under the terms of the agreement, EMC has agreed to provide a combination of content production and strategic digital media services over a 12-month term for a total payment US$250,000.
Emmaus Life Sciences Inc (OTCQX:EMMA) has announced that Dr Yutaka Niihara, its chairman and chief executive officer will present a company overview at the H.C. Wainwright BioConnect Conference, being held virtually, January 10-13, 2021. The on-demand presentation will be available beginning January 10, at 7.00am Eastern Time, on the "News and Events" section of Emmaus' website at: https://ir.emmausmedical.com/news-events and will be archived for a period of 90 days after the conference.
ElectraMeccanica (NASDAQ:SOLO) Vehicles Corp has announced that its management will participate in the 24th Annual Needham Growth Conference taking place virtually January 10-14, 2022. ElectraMeccanica (NASDAQ:SOLO) management is scheduled to participate in one-on-one meetings with investors throughout the event and will host a virtual presentation as follows on Monday, January 10, 2021, at 1.30pm Eastern time (12.30pm Pacific time) via the following webcast link: https://wsw.com/webcast/needham116/solo/2275042. Conference participation is by invitation only and registration is mandatory.
Biocept Inc (NASDAQ:BIOC) has announced that Michael Nall, its president and CEO, will present a company overview at the H.C. Wainwright BioConnect Virtual Conference being held January 10-13, 2022. A webcast of the Biocept presentation can be accessed on the Investor Relations section of the company website beginning on January 10, 2022, at 7.00am Eastern time. “Our priority in 2022 is to continue generating clinical data in order to further support adoption of CNSide, our proprietary cerebrospinal fluid assay for diagnosing and managing tumors that have metastasized to the central nervous system,” Nall said. “CNSide addresses a high unmet clinical need as metastatic brain cancer is extremely difficult to accurately diagnose using traditional tools and approaches. Physicians are using CNSide, together with newer therapies that target specific cancer mutations, to help patients who may have limited treatment options." He added: "We proudly continue assisting in the fight against the pandemic with RT-PCR COVID-19 testing services, which in turn, is helping to fund our long-term oncology strategy. We are pleased to begin the New Year by sharing our company presentation with the investment community.”
FSD Pharma (CSE:HUGE, NASDAQ:HUGE) Inc has announced that Anthony Durkacz, the company's interim CEO will present at the H.C. Wainwright Bioconnect Conference to be held virtually on January 10-13, 2022. The company said Durkacz’s presentation will be available on-demand for conference attendees starting at 7.00am ET on January 10, 2022. To register, investors can use the following link: https://hcwevents.com/bioconnect/. For more information about the conference, or to schedule a one-on-one meeting with FSD's management team, investors can contact KCSA Strategic Communications at fsdpharma@kcsa.com.
Context Therapeutics (NASDAQ:CNTX) Inc has announced that its chief executive officer Martin Lehr will participate virtually in two investor conferences in January 2022. The first, Biotech Showcase 2022, will take place January 10-12, 2022, and the company’s presentation will be available for on-demand viewing during the conference. Additionally, Lehr will participate on the “Women’s Health: Progress and Innovation Continue to Drive Increased Investor Interest” panel taking place on January 12, 2022, at 8.00am PST. Details about the event can be found here: https://informaconnect.com/biotech-showcase/agenda/4/. Secondly, at the Edison Group Open House: Global Healthcare 2022, which will take place January 25-27, 2022, and again the company’s presentation will be available for on-demand viewing during the conference, Context will also participate in one-on-one meetings during the conference. A replay of the company’s video presentation will be available on the Events page of the Investor Relations section of Context’s website, www.contexttherapeutics.com, for approximately 30 days after the meeting.
OTC Markets Group Inc, the operator of financial markets for over 11,000 US and global securities has announced that OM Holdings International Inc, a provider of a multi-tenant on-demand technology platform for the delivery of goods and services throughout the Caribbean, has qualified to trade on the OTCQX Best Market and has today upgraded from the OTC Pink market. The OTCQX Market provides investors with a premium US public market to research and trade the shares of investor-focused companies. Graduating to the OTCQX Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among US investors. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. “We are thrilled to see OMHI begin trading on the OTCQX Market,” said OMH CEO Mark Vanterpool. “OMHI has been building new stores and gaining market share consistently, even during the pandemic, and we believe we are poised for even greater growth in 2022 and beyond. Graduating to the OTCQX Market will give us enhanced visibility and, ultimately, greater liquidity. We see being a transparent and investor-focused public company as one of our brand’s core values, and trading on the OTCQX Market is core to our growth strategy.”